INTRODUCTION
In this report we describe the design and rationale of a depression and anxiety prevention pilot study focused on older adults with mild cognitive impairment (MCI) and their support persons, "Retaining Cognition while Avoiding Late-Life Depression (ReCALL)." We focus on individuals with MCI and their support persons because depressive and anxiety symptoms frequently co-occur with MCI, [1] [2] [3] and unpaid caregivers of individuals with MCI are also at increased risk for depression and anxiety due to the stresses related to caregiving. 1, 4 Further, MCI is often a transitional state between normal cognitive function and dementia (roughly one-third of individuals with MCI later develop dementia), 5 and neuropsychiatric symptoms, particularly depressive symptoms, may be modifiable risk factors to slow cognitive decline and prevent dementia. 6 Although the extant literature is not yet clear on how strong a risk factor is depressive symptomatology for dementia conversion, older adults with depressive symptoms, either major or subsyndromal depression, do have increased risk of progression to allcause dementia. 7, 8 Further, targeting treatment of subsyndromal depression may also have an impact on disability in individuals with MCI. 9, 10 Additionally, although stresses associated with dementia caregiving (e.g., dealing with changes in behavior and personality, dealing with functional and physical decline, needing to provide more supervision, anticipatory grief) are not present to the same extent in MCI caregiving, research by our group and others has shown that MCI support persons endorsed elevated levels of taskrelated responsibilities, subjective caregiver burden, and anticipatory grief. 1, 4, 11 Syndromal and subsyndromal depressive and anxiety symptoms in MCI likely have multiple etiologies. The underlying neuropathology that causes cognitive dysfunction may also disrupt the neural circuits involved in mood regulation. 12 However, cognitive loss may also act as a psychosocial stressor, leading to increased depression risk. There appears to be a bidirectional relationship between neuropsychiatric symptoms (depressive symptoms) and cognitive decline; having one condition enhances the risk of developing or worsening the other. 3, [13] [14] [15] [16] Mechanistically, depressive symptoms may increase the risk of further cognitive decline through multiple neurobiologic mechanisms (i.e., vascular, neurodegenerative, stress hormone toxicity), probably partially mediated by neuroinflammation. 12 For this pilot intervention development study, we chose to examine two interventions that might prevent major depression and anxiety disorders in older adults with MCI and their support persons, problem-solving therapy (PST) and moderate-intensity physical exercise (PE). Because both the individuals with MCI and their support persons are at increased risk for depression and anxiety disorders, we decided to take an innovative approach in developing an intervention that would be targeted at both members of a dyad at the same time, not previously examined in this population. The support person was to play a dual role: both as recipient of PST for depression/anxiety disorder prevention in him-or herself and as a PST "coach" for their MCI partner. The rationale for PST is that older adults with MCI have heterogeneous cognitive deficits, but the most common (e.g., slowed information processing, impaired memory, and executive dysfunction) compromise problem-solving.
PST is based on the premise that problem-solving deficits lead to ineffective coping, worsening life stress, and ultimately depressive symptoms (syndromal or subsyndromal) in those at risk. 17 PST teaches individuals to systematically approach and solve problems, exerting control over them. Once learned, the PST skills can be used to alleviate depressive symptoms and potentially mitigate depression risk. 18 Alexopoulos et al. 19, 20 have reported that modified PST improved problemsolving skills that alleviated depressive symptoms and disability in individuals with late-life depressionexecutive dysfunction syndrome. Recently, Kiosses et al. 21 demonstrated that 12 weeks of problem adaptation therapy, based on PST but focused on developing personalized strategies to regulate situations or problems that trigger negative emotions, was more effective than comparable supportive therapy for cognitively impaired adults 65 years and older with major depression.
PE is efficacious in older adults for reducing depressive symptoms 22, 23 and may protect against new major depressive episodes. 24, 25 Further, most older adults do not engage in the recommended amount of PE. Modest increases in physical activity may not only prevent depressive symptoms in vulnerable elders but may also have substantial general health benefits, including slowing cognitive decline. 26, 27 In this report we discuss how we addressed difficulties in the implementation of the study, most of which were not anticipated when the study was designed. We share our experience with the research community to help others in designing future studies involving depression and anxiety prevention in a vulnerable population of older adults and their caregivers.
METHODS

Specific Aims and Overall Study Design
We conducted a pilot randomized clinical trial to examine the following:
• This project has consisted of two phases. Phase I, now completed, focused on developing and standardizing PST to be delivered to the MCI participant and their support person together (dyadically) and implementing moderate-intensity PE. Phase II has focused on deploying the interventions in a randomized clinical trial.
The study design is shown in Figure 1 . In Phase II, after baseline assessment (T1), participants were randomly assigned to one of three cells (1:1:1): PST + PE, PST, or enhanced usual care (EUC, that is, usual care enhanced by the provision of research assessment results to the usual care clinician). The interventions are described below. After the acute intervention, lasting up to 16 weeks (or 12 weeks for those in EUC), participants have postintervention assessment (T2) and are assessed every 3 months (T3-T6) for 12 months.
Participants (inclusion/exclusion criteria)
To enter the study, probands (those with MCI) were 60 years or older; had a score on the Patient Health Questionnaire-9 28 > 1 with at least a score of 1 on question 1 or 2 (depressed mood or anhedonia) and did not meet criteria for a major depressive episode or current anxiety disorder, except for specific phobia 
(Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision);
35 had adequate physical and sensory function to undergo neuropsychological assessment; and were able to engage in moderateintensity exercise (e.g., brisk walking 30 minutes 3 times a week).
MCI diagnosis was conferred through a two-step process. First was an initial cognitive screening battery comprising the Modified Mini-Mental State Exam, 36 Trail Making A and B, 37 Digit Symbol Substitution, 38 and the Quick Mild Cognitive Impairment Screen (Qmci). 39 Individuals testing in the normal range (<1 SD below normed mean on all three tests and/or Qmci) or whose scores reflected dementia (either >2 SD below normed means on all three tests or >2 SD below normed means on the Qmci) were screened out. Based on the most common psychometric definition of MCI, individuals who scored between <1 and <2 below the normed mean on any test moved on to the comprehensive assessment and diagnostic adjudication session to determine MCI status. We acknowledge that the first level of MCI screening may have inadvertently screened out a small number of individuals as demented or normal who had early MCI. For those who screened in (or were questionably demented or normal), the initial cognitive screen was followed by more comprehensive assessment involving the Wide Range Achievement Test-IV Reading Subtest, 40 Repeatable Battery for the Assessment of Neuropsychological Status, 41 DelisKaplan Executive Function System Trail Making and Color-Word Tests, 42 Informant Questionnaire on cognitive decline in the elderly (IQCODE), 43 three-item version of the Performance Assessment of Self-Care Skills 44 (medication and finance management, flashlight repair), Clinical Dementia Rating Scale, and the Unified Parkinson's Disease Rating Scale. 50 The comprehensive assessment was reviewed at a diagnostic adjudication conference by a neuropsychologist, neurologist, and geriatric psychiatrist in which the National Institute on Aging-Alzheimer's Association criteria 51 were used to diagnose dementia or the National Alzheimer's Coordinating Center comprehensive criteria/Revised Petersen criteria (2004) to diagnose MCI. 52 We did not require subjective cognitive complaints on the part of the MCI participant but rather complaints from an informant, via the IQCODE. The information from the informant on the IQCODE was used in the consensus conference to determine whether there had been a change in cognitive function from a previously higher level. To determine whether an elderly person had declined, we used a cutoff of 3.2 in addition to clinical interpretation of the IQCODE.
Exclusion criteria for the MCI proband included any disorder affecting the central nervous system (e.g., multiple sclerosis), depression in the past year, substance use disorder in the past year, currently taking an antidepressant, or lifetime history of bipolar disorder or schizophrenia. The inclusion/exclusion criteria were designed to capture a heterogeneous group of older adults with MCI with subsyndromal depression but who did not have other conditions that would require treatment outside the scope of the study.
Inclusion/exclusion criteria for the support person were more limited: age ≥ 18 and normal cognitive function, no central nervous system disorder, substance use disorder in the past year, or lifetime history of bipolar disorder or schizophrenia. Support persons underwent the same two-step cognitive screening procedures as for the MCI participant to ensure no cognitive disorder was present.
Recruitment
Recruitment was initially planned from primary care physician offices and community agencies concentrated in low-income communities with whom our research has a history of collaborating. In addition, we collaborated with the University of Pittsburgh Alzheimer's Disease Research Center, who referred appropriate participants (those diagnosed with MCI) to our study.
Schedule of Assessments
The primary outcome is time to onset of major depression or anxiety disorder. We emphasize that depression/anxiety prevention interventions may not decrease the frequency of developing a major depressive episode or anxiety disorder but may delay their onset. We determined onset of major depressive episodes (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision) and anxiety disorders with the Primary Care Evaluation of Mental Disorders (PRIME-MD)/Mini-International Neuropsychiatric Interview. 53, 54 Symptom burden has been measured at all research assessments. Participants meeting diagnoses have been referred for treatment but have continued with research follow-up assessments. Independent evaluators blind to randomized intervention assignment have assessed subjects by phone or in person. Participants have been assessed at six time points: preintervention (T1), postintervention (T2), and subsequently at 3-month intervals (T3-T6) with an assessment battery that was shared and identical with other depression prevention studies conducted in our center (Table 1) .
Interventions
PST-cog
Our therapy was based on manuals for individuals with cognitive loss developed by co-investigator Dr. Linda Garand and consultants to our study, Drs. Patricia Arean and Dimitris Kiosses. Dr. Arean developed PST to treat older adults with depression and executive dysfunction, 20 and Dr. Kiosses developed PST to target elders with major depression and cognitive impairment. 21 As part of Dr. Kiosses' intervention, he developed and cataloged an array of tools to help with cognitive disabilities. Dr. Garand developed an intervention targeted at spouses of persons with MCI. 58 When needed, the Kiosses intervention engages the caregiver in treatment such as facilitating the problemsolving process, promoting pleasurable activities, and helping the cognitively impaired participant avoid negatively charged situations. However, none of the interventions was designed to be delivered to dyads exclusively. We thus integrated these therapies into a dyadic intervention, one that is delivered to both members of a dyad at the same time, focused on preventing depression and enhancing cognitive function in individuals with MCI and depressive symptoms and preventing depression in support persons. Based on work by Rovner et al., 59 participants in the treatment arm received booster sessions at 3 and 9 months following the end of the prevention intervention.
Training of Interventionists
Interventionists were master's-level therapists with greater than 10 years' experience in mental health intervention. A PST master trainer (JQM) supervised the interventionists and reviewed audiotapes of sessions to assess fidelity to training and suggest therapeutic strategies over the course of the intervention.
PE
Moderate-intensity PE was defined as any activity, such as walking, bicycling, and home aerobics, that would raise heart rate and would make breathing harder ("You'll be able to talk, but not to sing a song"). Subjects were encouraged to pursue whatever form of PE they preferred, specifically increasing their baseline activity level by 30 minutes three times per week. As an attention control for participants randomized to PST without PE, we instructed participants to use stretching bands three times weekly for 30 minutes for nonaerobic exercise. 60 For participants in engaged in PE or using stretching bands, these activities were Notes: IL-6: interleukin-6; TNF-α: tumor necrosis factor-α. monitored and encouraged by the PST therapist "outside the frame" of therapy (i.e., before or after the session devoted to PST). If the participant identified engaging in these activities as a problem to address in PST, then it was addressed "within the frame" of therapy. Participants were asked to complete activity logs of how often they exercised or used stretching bands.
EUC
Participants assigned to EUC received the same assessments as those participants assigned to PST or PST + PE but did not receive PST or PE. The usual care control arm was considered "enhanced" because participants were assessed for mood and cognitive problems on a regular basis, and those who met criteria for depression or anxiety disorders, cognitive decline, or who reported new medical symptoms were referred for medical care, as in the intervention arm.
RESULTS
Phase I: Developing, Piloting, and Standardizing the Study Interventions
Roughly 6 months were spent in treatment development and standardization. The team held "brainstorming" sessions to design the scope of the therapy, number and length of sessions, frequency of meetings, and role for booster sessions. In adapting PST for our study, we decided to make the support person serve as the "auxiliary brain" and "coach" for the MCI proband. Specifically, the support person would help the MCI proband when she or he had cognitive difficulties, such as memory impairment or executive dysfunction, as well as provide encouragement to follow through the PST steps. Although we did not expect the support person to serve as a therapist, we wanted her or him to be sufficiently skilled with PST to assist or coach the MCI subject to use PST effectively and be able to apply PST for her-or himself.
PST sessions were held with both members of the dyad present together, focusing on the MCI proband as the patient and working with the support person to serve as the coach. For MCI probands we often used "pleasant events" both to support behavioral activation, targeting behaviors that are "antidepressant" rather than internal factors such as cognitions, and to provide a working example to teach the PST steps. Although not prescriptive, we encouraged exploration of sleep disturbances as a problem in PST. We focused on sleep disturbances given the impact of disturbed sleep on mood and cognition. 61 To help identify sleep problems, participants randomized to PST or PST and PE were asked to complete a sleep diary after baseline evaluation. Support persons were also taught basic PST steps, not just to help work with their partner (as a coach) but also to apply PST to themselves for a selfidentified problem that was the focus of one session, in which the MCI proband and the support person, separately, worked on solving a problem.
In phase I we identified potential problems with the use of PST that might occur with participants. For example, we noted that for some married couples it was necessary to place limits on the scope of therapy, explicitly stating that marital therapy was beyond the scope of the intervention. However, some marital issues were appropriate for PST; for example, one dyad indicated they wanted to be "more social as a couple." Other issues were related to coaching. Some MCI participants disliked being coached by their spouses. Additionally, some support persons were natural coaches, whereas others needed to develop their coaching skills. We identified when coaching was "going with" or "going against the grain" of the relationship.
Importantly, before initiating PST, we planned that all participants, including those assigned to EUC, would have a "meet and greet" session in which the overall study was reviewed, including the overall study benefits. The cognitive test results would be discussed, and, in particular, we would discuss in detail the MCI diagnosis and its implications. A goal of the session would be to enhance motivation for study participation. Further, if a dyad was participating, another goal of the meeting would be to gauge interpersonal style and assess the dynamics of the dyad to understand how they would work as a team in learning and applying PST. The format of the meet and greet was optimized in Phase I.
We also piloted the PE intervention and use of devices that served to monitor physical activity via accelerometry and physiologic monitoring (e.g., heat fluctuation). In Phase I both MCI probands and support persons were asked to record the amount of time they exercised and if they were able to increase their baseline activity level by 90 minutes per week. Interventionists asked about PE before or after PST sessions, addressing obstacles to increasing their activity level and motivating participants to engage in increased PE. Additionally, we used Sensewear accelerometers (Body Media, Pittsburgh, PA, USA) at study start and midway through the intervention to monitor PE as well as the first week of the follow-up phase of the study to examine the durability of increasing PE.
Phase II: Implementing the Study Interventions and Addressing Problems with Recruitment
Because this prevention intervention development project was conducted in preparation for a confirmatory R01 grant, we expected that many changes to the protocol would be required during Phase II. Developmental and methodologic changes are summarized in Table 2 . The primary challenge with this phase was recruitment. Many modifications made to the study related to enhancing recruitment, ensuring that participants who were recruited reflected the larger community of older adults, and making the study findings generalizable. Figure 2 presents the number of participants screened, eligible, and enrolled. The most important issue was that by year 2 of the project, we determined that substantial numbers of interested and otherwise eligible participants were excluded because they did not have an eligible or willing support person.
TABLE 2. Developmental and methodologic challenges and changes
Challenges Solutions
We anticipated PST steps would be challenging for MCI participants to learn.
We used Alexopoulos and Arean's modifications for executive impairment, which included modifications for affect regulation, perseveration, and initiation deficits. We further modified PST by building in additional repetition of material to accommodate memory impairment. PST is self-oriented, and we were using it dyadically so the support person could coach the MCI proband to carry out the steps after the intervention period concluded.
Modified PST to first teach steps to the support person and then teach coaching skill to aid the MCI participant.
A substantial number of potential participants were screened out because they did not endorse dysphoria or anhedonia on the PHQ-2.
We requested permission to recontact these potential participants 3 months later to rescreen them with the PHQ-2. A substantial number of interested and otherwise eligible participants were excluded because they did not have a caregiver or the caregiver was ineligible or uninterested in research participation.
We opened up recruitment to individuals with MCI who did not have a caregiver ("singletons").
Inability of individuals with MCI to identify having MCI hampered recruitment.
We arranged and delivered presentations on cognitive aging in residences and community centers followed by on-site study screening of interested potential participants. Early recruitment was skewed to individuals who were minimally symptomatic because of the inclusion/exclusion criteria, excluding participants with PHQ-9 > 9.
We adjusted study inclusion criteria by removing the ceiling on PHQ-9 scores as long as participants had not experienced a major depressive episode within the previous 12 months. Early attempts by study staff to obtain blood for biomarker measurement resulted in low yield.
We hired a phlebotomist to travel to participants' homes to draw blood.
Notes: PHQ: Patient Health Questionnaire. Further, given the high rate of older adults who live alone, including those with MCI, not including older adults who live alone would limit the generalizability of the study findings. 57 We therefore opened up recruitment to individuals with MCI who did not have a caregiver ("singletons").
We also identified other challenges to enrollment: (1) Most people in the community living with MCI are undiagnosed and therefore unaware of the disorder (i.e., may identify their difficulties as normal aging) and (2) screening and evaluating communitydwelling older adults for MCI was much more laborintensive than initially planned. Although there was little that we could do regarding challenge 1, regarding challenge 2 we redirected and expanded resources to recruitment.
Recruitment Strategies
No one particular recruitment method was effective. Rather a multipronged approach was required. It involved scouring research registries, encouraging word of mouth by community champions and prior research subjects, mailings targeted to older adults, and, most importantly, faculty presentations discussing cognitive aging at senior centers and senior high rises immediately followed by cognitive screening of individuals interested in the study participation.
Compliance, Uptake, and Fidelity
We have tracked the uptake of PST by MCI participants. In general, they were able to learn and apply problem-solving skills via PST. At the end of every PST session, the interventionist filled out a three-point rating scale (1 = lowest, 3 = highest) aimed at assessing uptake. Among subjects who completed the study (N = 37) versus those who dropped out (N = 3), participation was 2.90 versus 3.00, understanding of material was 2.77 versus 2.28, and homework effort and participation was 2.53 versus 2.24.
We recruited 94 participants (Table 3 ) and enrolled 20 MCI subjects with 20 support persons (i.e., 20 dyads); the remainder of the subjects (N = 54) were all MCI singletons. Nonwhite participation was significantly higher than the demographics of Allegheny County (18.7%). 
Patient Satisfaction
We surveyed 20 MCI participants after study completion. Because the study team is still blinded, data are combined across intervention groups. For items on flexibility of scheduling study appointments and helpfulness of the therapist, 100% were "satisfied" or "highly satisfied"; frequency of appointments and usefulness of the interventions in managing stress, 95% were "satisfied" or "highly satisfied"; and on usefulness in managing cognitive problems, 89% were "satisfied" or "highly satisfied." In addition, 12 participants completed an additional questionnaire, and 83% (10/12) were willing to participate in a future exercise intervention study, and 80% (8/10) of those were very willing or somewhat willing to participate in a community site an average of 2.4 sessions per week. Of those, 63% (5/8) preferred a 6-month study duration.
DISCUSSION
We have presented the key aspects of the implementation and challenges we encountered to help the community of researchers learn from our efforts. The study findings will be reported after study completion in January 2016. In the coming years depression and anxiety prevention studies will be increasingly important with the aging population of high-, middle-, and low-income countries; the United States; and the developed world. Our take-home points to our fellow researchers in geriatric mental health for maximizing feasibility and acceptability of depression and anxiety prevention research in MCI probands and their support persons are as follows. First, prevention work is feasible with adequate resources directed for recruitment. Second, when recruiting individuals at risk for depression and anxiety, it is important to avoid making inclusion/exclusion criteria too restrictive, such that individuals who are most symptomatic but do not meet diagnostic criteria for depression are excluded, because these are the individuals who are most likely to benefit from depression prevention interventions (i.e., indicated prevention). Third, individuals with cognitive impairment are often unaware of their cognitive diagnosis and may not "self-identify" for research studies of cognitive dysfunction. To address this selfidentification problem, it is critical to combine research recruitment efforts with simultaneous screening for cognitive dysfunction. Fourth, support persons can be trained as PST coaches to promote positive aspects of their relationship. However, individuals with MCI often have limited or no support, so PST depression/anxiety prevention needs to be flexibly designed to include or not include support persons. By publishing our methods, design, and issues with implementations, we expect that other researchers will benefit from our experience with our intervention development study ReCALL.
